Lutein and Ultram drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lutein (lutein) and Ultram (tramadol hydrochloride). Common drug interactions include oedema peripheral among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Lutein and Ultram. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Lutein?

Lutein has active ingredients of lutein. It is often used in macular degeneration. eHealthMe is studying from 7,461 Lutein users. Check the latest studies of Lutein.

What is Ultram?

Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

50 people who take Lutein and Ultram together, and have interactions are studied.

Lutein and Ultram drug interactions.

What are the common drug interactions of Lutein and Ultram, by gender? *:

female:

  1. Oedema peripheral (superficial swelling)
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  4. Road traffic accident
  5. Stress
  6. Transient global amnesia (a temporary short-term memory loss)
  7. Weight decreased
  8. Death
  9. Abdominal pain
  10. Arthralgia (joint pain)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Hypotension (abnormally low blood pressure)
  4. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  5. Renal failure (kidney dysfunction)
  6. Agitation (state of anxiety or nervous excitement)
  7. Balance disorder
  8. Blood creatinine increased
  9. Blood disorder
  10. Blood uric acid increased

What are the common drug interactions of Lutein and Ultram, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  3. Muscular weakness (muscle weakness)
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  6. Stress
  7. Urinary tract infection
  8. Abdominal pain
  9. Colitis (inflammation of colon)
  10. Diarrhoea

40-49:

n/a

50-59:

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  2. Medical device complication
  3. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)

60+:

  1. Fall
  2. Foot fracture
  3. Muscle spasms (muscle contraction)
  4. Pneumonia
  5. Vomiting
  6. Chest pain
  7. Confusional state
  8. Dehydration (dryness resulting from the removal of water)
  9. Febrile neutropenia (fever with reduced white blood cells)
  10. Hypokalaemia (low potassium)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 12.00%
  2. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 10.00%
  3. Nausea (feeling of having an urge to vomit): 4 people, 8.00%
  4. Muscle Spasms (muscle contraction): 4 people, 8.00%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 8.00%
  6. Drowsiness: 4 people, 8.00%
  7. Asthma: 4 people, 8.00%
  8. Osteoporosis (bones weak and more likely to break): 3 people, 6.00%
  9. Migraine (headache): 3 people, 6.00%
  10. Insomnia (sleeplessness): 3 people, 6.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lutein and Ultram?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lutein and Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lutein:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lutein and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ultram and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lutein and tramadol hydrochloride (the active ingredients of Lutein and Ultram, respectively), and Lutein and Ultram (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: